Capital Fund Management (CFM)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.81M | Sell |
41,700
-180,500
| -81% | -$25.3M | 0.03% | 823 |
|
|
2025
Q4 | $27.3M | Buy |
222,200
+37,800
| +20% | +$4.59M | 0.08% | 359 |
|
|
2025
Q3 | $20.5M | Sell |
184,400
-30,300
| -14% | -$3.44M | 0.05% | 507 |
|
|
2025
Q2 | $23.8M | Sell |
214,700
-259,400
| -55% | -$27.6M | 0.07% | 403 |
|
|
2025
Q1 | $53.1M | Sell |
474,100
-21,300
| -4% | -$2.2M | 0.15% | 185 |
|
|
2024
Q4 | $45.8M | Buy |
495,400
+25,400
| +5% | +$2.29M | 0.12% | 247 |
|
|
2024
Q3 | $39.4M | Sell |
470,000
-109,100
| -19% | -$8.32M | 0.11% | 253 |
|
|
2024
Q2 | $39.7M | Buy |
579,100
+186,100
| +47% | +$12.4M | 0.12% | 238 |
|
|
2024
Q1 | $28.8M | Sell |
393,000
-422,100
| -52% | -$32.5M | 0.08% | 322 |
|
|
2023
Q4 | $66M | Sell |
815,100
-34,700
| -4% | -$2.7M | 0.18% | 131 |
|
|
2023
Q3 | $63.7M | Buy |
849,800
+208,100
| +32% | +$16M | 0.22% | 116 |
|
|
2023
Q2 | $49.5M | Sell |
641,700
-209,000
| -25% | -$16.7M | 0.2% | 126 |
|
|
2023
Q1 | $70.6M | Buy |
850,700
+643,500
| +311% | +$53.3M | 0.34% | 61 |
|
|
2022
Q4 | $17.8M | Buy |
207,200
+147,600
| +248% | +$11.7M | 0.12% | 235 |
|
|
2022
Q3 | $3.68M | Sell |
59,600
-87,800
| -60% | -$5.54M | 0.03% | 651 |
|
|
2022
Q2 | $9.11M | Sell |
147,400
-68,200
| -32% | -$4.22M | 0.08% | 335 |
|
|
2022
Q1 | $12.8M | Buy |
215,600
+148,500
| +221% | +$9.49M | 0.1% | 280 |
|
|
2021
Q4 | $4.87M | Sell |
67,100
-155,900
| -70% | -$10.7M | 0.04% | 652 |
|
|
2021
Q3 | $15.6M | Sell |
223,000
-335,600
| -60% | -$23.6M | 0.12% | 236 |
|
|
2021
Q2 | $38.5M | Sell |
558,600
-176,300
| -24% | -$11.8M | 0.3% | 68 |
|
|
2021
Q1 | $47.5M | Buy |
734,900
+641,700
| +689% | +$41.4M | 0.52% | 29 |
|
|
2020
Q4 | $5.43M | Buy |
93,200
+49,100
| +111% | +$2.96M | 0.05% | 433 |
|
|
2020
Q3 | $2.79M | Buy |
+44,100
| New | +$3.06M | 0.03% | 539 |
|
|
2019
Q1 | – | Sell |
-39,600
| Closed | -$2.48M | – | 1828 |
|
|
2018
Q4 | $2.48M | Sell |
39,600
-54,400
| -58% | -$3.8M | 0.02% | 764 |
|
|
2018
Q3 | $7.26M | Sell |
94,000
-5,400
| -5% | -$408K | 0.04% | 615 |
|
|
2018
Q2 | $7.04M | Buy |
99,400
+49,200
| +98% | +$3.47M | 0.04% | 588 |
|
|
2018
Q1 | $3.79M | Buy |
50,200
+9,400
| +23% | +$747K | 0.02% | 781 |
|
|
2017
Q4 | $2.92M | Sell |
40,800
-253,300
| -86% | -$19.2M | 0.02% | 849 |
|
|
2017
Q3 | $23.8M | Buy |
+294,100
| New | +$22.5M | 0.17% | 165 |
|
|
2017
Q2 | – | Sell |
-56,000
| Closed | -$3.8M | – | 1550 |
|
|
2017
Q1 | $3.8M | Buy |
+56,000
| New | +$3.94M | 0.03% | 565 |
|
|
2016
Q3 | – | Sell |
-2,900
| Closed | -$242K | – | 1653 |
|
|
2016
Q2 | $242K | Sell |
2,900
-22,000
| -88% | -$1.95M | ﹤0.01% | 1386 |
|
|
2016
Q1 | $2.29M | Buy |
24,900
+3,500
| +16% | +$316K | 0.02% | 665 |
|
|
2015
Q4 | $2.17M | Sell |
21,400
-55,500
| -72% | -$5.77M | 0.02% | 651 |
|
|
2015
Q3 | $7.55M | Buy |
76,900
+58,300
| +313% | +$6.47M | 0.08% | 293 |
|
|
2015
Q2 | $2.18M | Sell |
18,600
-22,100
| -54% | -$2.41M | 0.03% | 600 |
|
|
2015
Q1 | $3.99M | Sell |
40,700
-385,400
| -90% | -$39.1M | 0.05% | 406 |
|
|
2014
Q4 | $40.2M | Buy |
426,100
+32,900
| +8% | +$3.4M | 0.48% | 28 |
|
|
2014
Q3 | $41.9M | Sell |
393,200
-143,200
| -27% | -$14M | 0.47% | 30 |
|
|
2014
Q2 | $44.5M | Buy |
536,400
+426,900
| +390% | +$33.2M | 0.47% | 25 |
|
|
2014
Q1 | $7.76M | Sell |
109,500
-209,000
| -66% | -$16.4M | 0.09% | 251 |
|
|
2013
Q4 | $23.9M | Sell |
318,500
-141,500
| -31% | -$9.85M | 0.3% | 45 |
|
|
2013
Q3 | $28.9M | Buy |
460,000
+13,500
| +3% | +$807K | 0.4% | 40 |
|
|
2013
Q2 | $22.9M | Buy |
+446,500
| New | +$23.3M | 0.35% | 34 |
|
Other funds holding GILD
VCM
VPM
Capital Fund Management (CFM)'s GILD Position: Q1 2026 in Review
Capital Fund Management (CFM) increased its Gilead Sciences (GILD) stake by 97% in Q1 2026, buying an estimated $5.06M and bringing the position to 73,592 shares worth $10.3M. The position accounts for 0.05% of the portfolio, ranked #542.
Capital Fund Management (CFM) first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $94.3M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Capital Fund Management (CFM) held 73,592 shares of Gilead Sciences worth $10.3M as of Q1 2026.
- Capital Fund Management (CFM) bought 36,156 Gilead Sciences shares in Q1 2026, an estimated $5.06M.
- Gilead Sciences made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #542 holding.
- Capital Fund Management (CFM) first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- Capital Fund Management (CFM)'s Gilead Sciences position peaked at $94.3M in Q1 2016.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.